DIAMEDICA THERAPEUTICS INC (DMAC) Top Institutional Shareholders

DIAMEDICA THERAPEUTICS INC (DMAC) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $78.53M in DMAC holdings during the latest filing period.

Cooperman Leon G is currently the largest disclosed institutional shareholder of DMAC tracked by InsiderSet, reporting ownership valued at approximately $13.68M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $11.57M, representing an estimated loss of -15.36% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 74% of the total disclosed DMAC value among the investors covered in this analysis. Major shareholders include Cooperman Leon G, Blackrock, Inc., Millennium Management Llc, and several other long-term asset managers with concentrated positions in DIAMEDICA THERAPEUTICS INC (DMAC).

This page ranks the largest institutional DMAC shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

96

Total Reported Value

$78.53M

Largest Holder

Cooperman Leon G

Largest Position

$13.68M

Insider Transactions (90d)

0

Latest Filing Quarter

Q1 2026

New Institutional Positions

109

Funds Exiting Positions

0

Page 1 of 2
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Cooperman Leon G0.45%2,020,000$13,675,400$11,574,600-$2,100,800-15.36%
Blackrock, Inc.0.00%1,856,187$12,566,385$10,635,952-$1,930,433-15.36%
Millennium Management Llc0.00%935,592$6,333,958$5,360,942-$973,016-15.36%
Paragon Associates & Paragon Associates Ii Joint Venture8.05%875,000$5,923,750$5,013,750-$910,000-15.36%
Geode Capital Management, Llc0.00%780,516$5,285,410$4,472,357-$813,053-15.38%
State Street Corp0.00%644,211$4,361,308$3,691,329-$669,979-15.36%
First Manhattan Co. Llc.0.01%455,000$3,080,350$2,607,150-$473,200-15.36%
Bleichroeder Lp0.45%382,317$2,588,286$2,190,676-$397,610-15.36%
Northern Trust Corp0.00%338,526$2,291,822$1,939,754-$352,068-15.36%
Vanguard Capital Management Llc0.00%333,456$2,257,497$1,910,703-$346,794-15.36%
Osaic Holdings, Inc.0.00%319,675$2,164,198$1,831,738-$332,460-15.36%
Lpl Financial Llc0.00%226,050$1,530,359$1,295,267-$235,093-15.36%
Vanguard Portfolio Management Llc0.00%203,459$1,377,417$1,165,820-$211,597-15.36%
Vanguard Fiduciary Trust Co0.00%187,724$1,270,891$1,075,659-$195,232-15.36%
Citadel Advisors Llc0.00%145,724$986,551$834,999-$151,552-15.36%
Sei Investments Co0.00%111,320$753,636$637,864-$115,772-15.36%
Bank Of New York Mellon Corp0.00%111,079$752,001$636,483-$115,518-15.36%
Morgan Stanley0.00%105,420$713,694$604,057-$109,637-15.36%
Members Wealth Llc0.39%101,382$655,942$580,919-$75,023-11.44%
Informed Momentum Co Llc0.07%91,425$618,947$523,865-$95,082-15.36%
Charles Schwab Investment Management Inc0.00%88,421$598,610$506,652-$91,958-15.36%
Nuveen, Llc0.00%79,110$535,574$453,300-$82,274-15.36%
Magnolia Capital Advisors Llc0.10%77,405$524,032$443,531-$80,501-15.36%
Blue Trust, Inc.0.01%69,122$467,956$396,069-$71,887-15.36%
Kalehua Capital Management Llc0.36%62,488$423,044$358,056-$64,988-15.36%
Exoduspoint Capital Management, Lp0.00%60,011$406,274$343,863-$62,411-15.36%
Corient Ia Llc0.38%60,000$406,200$343,800-$62,400-15.36%
Goldman Sachs Group Inc0.00%59,288$401,380$339,720-$61,660-15.36%
Renaissance Technologies LLCJim Simons0.00%52,523$355,581$300,957-$54,624-15.36%
Private Capital Management, Llc0.03%50,000$338,500$286,500-$52,000-15.36%
Meridian Wealth Management, Llc0.01%48,641$329,300$278,713-$50,587-15.36%
Bank Of America Corp0.00%42,768$289,539$245,061-$44,478-15.36%
Catalyst Financial Partners Llc0.03%38,457$260,354$220,359-$39,995-15.36%
World Investment Advisors0.00%36,975$250,321$211,867-$38,454-15.36%
Awm Investment Company, Inc.0.03%36,000$243,720$206,280-$37,440-15.36%
Creative Planning0.00%33,599$227,465$192,522-$34,943-15.36%
Deutsche Bank Ag\0.00%28,354$191,956$162,468-$29,488-15.36%
Invesco Ltd.0.00%24,799$167,890$142,098-$25,792-15.36%
Royal Bank Of Canada0.00%23,343$157,000$133,755-$23,245-14.81%
Rhumbline Advisers0.00%22,753$154,031$130,375-$23,656-15.36%
Trexquant Investment Lp0.00%22,261$150,707$127,556-$23,151-15.36%
Quadrature Capital Ltd0.00%22,039$149,204$126,283-$22,921-15.36%
Susquehanna International Group, Llp0.00%21,650$146,571$124,055-$22,516-15.36%
Bank Of Montreal0.00%18,635$126,159$106,779-$19,380-15.36%
Stonebridge Capital Advisors Llc0.01%17,500$118,475$100,275-$18,200-15.36%
Cornerstone Wealth Management, Llc0.01%16,250$110,013$93,113-$16,901-15.36%
Mirae Asset Global Etfs Holdings Ltd.0.00%16,158$109,390$92,585-$16,805-15.36%
Wells Fargo & Company/Mn0.00%15,966$108,090$91,485-$16,605-15.36%
Raymond James Financial Inc0.00%15,791$106,905$90,482-$16,423-15.36%
Brevan Howard Capital Management Lp0.00%14,256$96,513$81,687-$14,826-15.36%

Frequently asked questions about DMAC

  • Who owns the most DMAC stock?

    The largest holders of DMAC are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for DIAMEDICA THERAPEUTICS INC (DMAC).

  • Is DMAC widely held by superinvestors?

    Many widely followed stocks like DMAC appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly DMAC is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.